New Data Presented at ATS 2021 International Conference Shows Positive, Sustained Benefits to Patients Treated with this First Minimally Invasive, Non-drug Treatment Option REDWOOD CITY, Calif., May ...
Chronic Obstructive Pulmonary Disease (COPD) and emphysema are debilitating conditions that can make even simple tasks like walking or climbing stairs feel insurmountable. For many in the Texas ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for severe lung disease, today announced the publication of long ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Pulmonx Corporation, a leader in therapeutic pulmonary device technologies, announced today that its Zephyr® Valve is now covered by Priority Health® under its ...
Approval of First Minimally Invasive Treatment Option in Japan that Helps Patients with Advanced Disease Breathe Easier and Have a Better Quality of Life Over 600,000 Japanese patients suffer from ...
The Zephyr Valve Helps COPD/Emphysema Patients Breathe Easier Without the Risk of Major Surgery 1 REDWOOD CITY, Calif., Nov. 30, 2020 (GLOBE NEWSWIRE) -- As part of COPD Awareness Month, Pulmonx ...
Pulmonx Corporation gains attention as healthcare strength highlights its emphysema-focused Zephyr Valve and Chartis patient ...
David Feller-Kopman, MD, section chief, pulmonary and critical care medicine and Elliot D. Backer, MD, tend to Lucy Mary Kempe, the first patient to receive the Zephyr Valve at Dartmouth-Hitchcock ...
Spectrum Health is one of the first hospitals in Michigan to offer a novel treatment for emphysema. The treatment uses the Zephyr® Valve system, an FDA-approved minimally invasive procedure requiring ...
Bakersfield Heart Hospital is the first in Central California to offer a new lung valve treatment for patients with severe COPD/emphysema. Recently approved by the FDA under their "Breakthrough ...
Eisenhower Health is the first hospital in Southern California to offer a new lung valve treatment for patients with severe COPD/emphysema. Recently approved by the FDA under their "Breakthrough ...